Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy. FE [Internet]. 2022 Feb. 7 [cited 2025 Oct. 29];23(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1510